Neprilisina (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Neprilisina" in Galician language version.

refsWebsite
Global rank Galician rank
4th place
6th place
2nd place
7th place
5,673rd place
1,707th place
149th place
162nd place
1,226th place
970th place
8,869th place
1,724th place

aacrjournals.org

cancerres.aacrjournals.org

bmj.com

jnnp.bmj.com

doi.org

dx.doi.org

  • Pardossi-Piquard, R.; Dunys J., Yu G., St George-Hyslop P., Alves da Costa C. and Checler F. (2006). "Neprilysin activity and expression are controlled by nicastrin". Journal of Neurochemistry 97 (4): 1052–6. PMID 16606360. doi:10.1111/j.1471-4159.2006.03822.x. 
  • Helisalmi, S; M. Hiltunen, S. Vepsäläinen, S. Iivonen, A. Mannermaa, M. Lehtovirta, A. M. Koivisto, I. Alafuzoff and H. Soininen (2004). "Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients". Journal of Neurology Neurosurgery and Psychiatry 75 (12): 1746–8. PMC 1738829. PMID 15548496. doi:10.1136/jnnp.2004.036574. Consultado o 2007-03-11. 
  • Madan, Rime; Raphael Poirier, David P. Wolfer, Hans Welzl, Peter Groscurth, Hans-Peter Lipp, Bao Lu, Mohammed El Mouedden, Marc Mercken, Roger M. Nitsch and M. Hasan Mohajeri (2006). "Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo". Journal of Neuroscience Research 84 (8): 1871–8. PMID 16998901. doi:10.1002/jnr.21074. 
  • Iwata, Nobuhisa; Satoshi Tsubuki, Yoshie Takaki, Kaori Watanabe, Misaki Sekiguchi, Emi Hosoki, Maho Kawashima-Morishima, Hahn-Jun Lee, Emi Hama, Yoko Sekine-Aizawa and Takaomi C. Saido (2000). "Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition". Nature Medicine 6 (2): 143–50. PMID 10655101. doi:10.1038/72237. 
  • Iwata, Nobuhisa; Makoto Higuchi and Takaomi C. Saido (2005). "Metabolism of amyloid-beta peptide and Alzheimer's disease". Pharmacology & Therapeutics 108 (2): 129–48. PMID 16112736. doi:10.1016/j.pharmthera.2005.03.010. 
  • Hama, Emi; Takaomi C. Saido (2005). "Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide". Medical Hypotheses 65 (3): 498–500. PMID 15921860. doi:10.1016/j.mehy.2005.02.045. 
  • Wang, Deng-Shun; Nobuhisa Iwata, Emi Hama, Takaomi C. Saido and Dennis W. Dickson (2003). "Oxidized neprilysin in aging and Alzheimer's disease brains". Biochemical and Biophysical Research Communications 310 (1): 236–41. PMID 14511676. doi:10.1016/j.bbrc.2003.09.003. 
  • Sahli, Stefan; Bernhard Stump, Tobias Welti, W. Bernd Schweizer, François Diederich, Denise Blum-Kaelin, Johannes D. Aebi and Hans-Joachim Böhm (2005). "A New Class of Inhibitors for the Metalloprotease Neprilysin Based on a Central Imidazole Scaffold". Helvetica Chimica Acta 88 (4): 707–730. doi:10.1002/hlca.200590050. 
  • Oefner, C.; B. P. Roques, M.-C. Fournie-Zaluski and G. E. Dale (2004). "Structural analysis of neprilysin with various specific and potent inhibitors". Acta Crystallographica D 60 (Pt 2): 392–396. PMID 14747736. doi:10.1107/S0907444903027410. 
  • Velasquez, Elsa F.; Molly Yancovitz, Anna Pavlick, Russell Berman, Richard Shapiro, Dusan Bogunovic, David O'Neill, Yi-Lo Yu, Joanna Spira, Paul J Christos, Xi Kathy Zhou, Madhu Mazumdar4, David M Nanus, Leonard Liebes, Nina Bhardwaj, David Polsky and Iman Osman (2007). "Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma". Journal of Translational Medicine 5 (2): 2. PMC 1770905. PMID 17207277. doi:10.1186/1479-5876-5-2. 

nih.gov

ncbi.nlm.nih.gov

  • Pardossi-Piquard, R.; Dunys J., Yu G., St George-Hyslop P., Alves da Costa C. and Checler F. (2006). "Neprilysin activity and expression are controlled by nicastrin". Journal of Neurochemistry 97 (4): 1052–6. PMID 16606360. doi:10.1111/j.1471-4159.2006.03822.x. 
  • Helisalmi, S; M. Hiltunen, S. Vepsäläinen, S. Iivonen, A. Mannermaa, M. Lehtovirta, A. M. Koivisto, I. Alafuzoff and H. Soininen (2004). "Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients". Journal of Neurology Neurosurgery and Psychiatry 75 (12): 1746–8. PMC 1738829. PMID 15548496. doi:10.1136/jnnp.2004.036574. Consultado o 2007-03-11. 
  • Madan, Rime; Raphael Poirier, David P. Wolfer, Hans Welzl, Peter Groscurth, Hans-Peter Lipp, Bao Lu, Mohammed El Mouedden, Marc Mercken, Roger M. Nitsch and M. Hasan Mohajeri (2006). "Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo". Journal of Neuroscience Research 84 (8): 1871–8. PMID 16998901. doi:10.1002/jnr.21074. 
  • Iwata, Nobuhisa; Satoshi Tsubuki, Yoshie Takaki, Kaori Watanabe, Misaki Sekiguchi, Emi Hosoki, Maho Kawashima-Morishima, Hahn-Jun Lee, Emi Hama, Yoko Sekine-Aizawa and Takaomi C. Saido (2000). "Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition". Nature Medicine 6 (2): 143–50. PMID 10655101. doi:10.1038/72237. 
  • Iwata, Nobuhisa; Makoto Higuchi and Takaomi C. Saido (2005). "Metabolism of amyloid-beta peptide and Alzheimer's disease". Pharmacology & Therapeutics 108 (2): 129–48. PMID 16112736. doi:10.1016/j.pharmthera.2005.03.010. 
  • Hama, Emi; Takaomi C. Saido (2005). "Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide". Medical Hypotheses 65 (3): 498–500. PMID 15921860. doi:10.1016/j.mehy.2005.02.045. 
  • Wang, Deng-Shun; Nobuhisa Iwata, Emi Hama, Takaomi C. Saido and Dennis W. Dickson (2003). "Oxidized neprilysin in aging and Alzheimer's disease brains". Biochemical and Biophysical Research Communications 310 (1): 236–41. PMID 14511676. doi:10.1016/j.bbrc.2003.09.003. 
  • Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004 Oct 1;383(Pt 1):45-51. PMID 15283675. [2]
  • Yandle TG, Brennan SO, Espiner EA, Nicholls MG, Richards AM. Endopeptidase-24.11 in human plasma degrades atrial natriuretic factor (ANF) to ANF(99-105/106-126). Peptides. 1989 Jul-Aug;10(4):891-4. PMID 2531377. [3]
  • Morisaki N, Moriwaki S, Sugiyama-Nakagiri Y, Haketa K, Takema Y, Imokawa G. Neprilysin is identical to skin fibroblast elastase: its role in skin aging and UV responses. J Biol Chem. 2010 Dec 17;285(51):39819-27. doi: 10.1074/jbc.M110.161547. Epub 2010 Sep 28. PMID 20876573. [4]
  • Oefner, C.; B. P. Roques, M.-C. Fournie-Zaluski and G. E. Dale (2004). "Structural analysis of neprilysin with various specific and potent inhibitors". Acta Crystallographica D 60 (Pt 2): 392–396. PMID 14747736. doi:10.1107/S0907444903027410. 
  • Velasquez, Elsa F.; Molly Yancovitz, Anna Pavlick, Russell Berman, Richard Shapiro, Dusan Bogunovic, David O'Neill, Yi-Lo Yu, Joanna Spira, Paul J Christos, Xi Kathy Zhou, Madhu Mazumdar4, David M Nanus, Leonard Liebes, Nina Bhardwaj, David Polsky and Iman Osman (2007). "Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma". Journal of Translational Medicine 5 (2): 2. PMC 1770905. PMID 17207277. doi:10.1186/1479-5876-5-2. 
  • Cohen, Andrea J.; Paul A. Bunn, Wilbur Franklin, Catherine Magill-Solc, Christa Hartmann, Barbara Heifrich, Laura Gilman, Joy Folkvord, Karen Helm, and York E. Miller (15 February 1996). "Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux". Cancer Research 56 (4): 831–9. PMID 8631021. Consultado o 2006-03-11. 
  • Alasbahi R, Melzig MF (2008). "Screening of some Yemeni medicinal plants for inhibitory activity against peptidases". Pharmazie 63 (1): 86–8. PMID 18271311. 

sciencedirect.com

  • Christian Oefnera, Allan D’Arcya, Michael Henniga, Fritz K Winklera, Glenn E Dalea. Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. Journal of Molecular Biology. Volume 296, Issue 2, 19 February 2000, Pages 341–349. [1]

uniprot.org